Financial reports
ARS
2023 FY
Annual report to shareholders
19 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
7 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
18 Apr 24
8-K
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
8-K
Departure of Directors or Certain Officers
20 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
13 Dec 23
8-K
Entry into a Material Definitive Agreement
3 Nov 23
8-K
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K
Entry into a Material Definitive Agreement
3 Oct 23
8-K
Departure of Directors or Certain Officers
20 Sep 23
8-K
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
20 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
26 Feb 24
S-3ASR
Automatic shelf registration
3 Nov 23
S-8
Registration of securities for employees
28 Feb 23
S-8
Registration of securities for employees
28 Feb 22
S-8
Registration of securities for employees
25 Feb 21
S-3ASR
Automatic shelf registration
10 Nov 20
424B4
Prospectus supplement with pricing info
8 Jul 20
POS EX
Additional exhibits for listing
8 Jul 20
S-1MEF
Registration of additional securities for an S-1
7 Jul 20
S-1
IPO registration
6 Jul 20
Proxies
DEFA14A
Additional proxy soliciting materials
19 Apr 24
DEF 14A
Definitive proxy
19 Apr 24
DEFA14A
Additional proxy soliciting materials
7 Apr 23
DEF 14A
Definitive proxy
7 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Apr 22
DEF 14A
Definitive proxy
7 Apr 22
DEFA14A
Additional proxy soliciting materials
6 Apr 21
DEF 14A
Definitive proxy
6 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
DEFA14A
Additional proxy soliciting materials
6 Apr 20
Other
EFFECT
Notice of effectiveness
8 Jul 20
CORRESP
Correspondence with SEC
6 Jul 20
CORRESP
Correspondence with SEC
6 Jul 20
UPLOAD
Letter from SEC
29 Jun 20
EFFECT
Notice of effectiveness
11 Oct 19
CERT
Certification of approval for exchange listing
10 Oct 19
CORRESP
Correspondence with SEC
8 Oct 19
CORRESP
Correspondence with SEC
8 Oct 19
CORRESP
Correspondence with SEC
30 Sep 19
SEC STAFF
SEC staff action: Order
20 Sep 19
Ownership
4
Backer Marianne De
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
4
ANN M. HANLY
2 Apr 24
4
Sung Lee
28 Mar 24
4
ANN M. HANLY
26 Feb 24
4
Backer Marianne De
26 Feb 24
4
Sung Lee
26 Feb 24
4
Phillip Pang
26 Feb 24
4
GEORGE A SCANGOS
26 Feb 24